Brind.

Rival company United Therapeutics outperformed Zoetis stock on September 5, 2025.

1 report, 1 independent Updated Sep 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

United Therapeutics Zoetis

Keep exploring

The entities involved

United Therapeutics
biotech company based in Silver Spring, Maryland, United States
- United Therapeutics filed Form 13F with the Securities and Exchange Commission.Mon 11:42
- Trump's tariff plan caused markets to tank, affecting company Flo.Sun 01:29
Zoetis
American animal health company

Nothing else this week.

Related events

United Therapeutics and Zenas are two healthcare companies that are currently competing for market share.Sep 7

Coverage

Newest first; wire copies grouped

Sep 5BarchartIs Zoetis Stock Underperforming the Nasdaq? Valued at a market cap of $67.6 billion, Zoetis Inc. (ZTS) is a global leader in animal health. The company develops, manufactures, and commercializes medi